In the present study, the hepatic expression level of FXR was up-regulated, while FGF19 and IBABP were down-regulated, which indicated that IUGR may activate intestinal FXR, induce expression of FGF19, and reduce bile acid reabsorption. The gene discussed is FABP6; the disease is fetal growth restriction.